Shilpa Medicare’s Plan For Eylea Biosimilar Spells Ambition, But Path Not Easy

Humira Biosimilar Trial Recruiting

Arrow being aimed at man flying with arrow in hand
Shilpa's Biosimilars Ambitions Could Face Obstacles • Source: Alamy
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from R&D

More from Scrip